|
Originally published In Press as doi:10.1074/jbc.M706592200 on September 11, 2007
J. Biol. Chem., Vol. 282, Issue 44, 32152-32157, November 2, 2007
Mediator Subunit MED28 (Magicin) Is a Repressor of Smooth Muscle Cell Differentiation*
Kim S. Beyer 1,
Roberta L. Beauchamp 1,
Ming-Fen Lee ,
James F. Gusella ,
Anders M. Näär , and
Vijaya Ramesh 2
From the
Molecular Neurogenetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts 02114 and Massachusetts General Hospital Cancer Center, Department of Cell Biology, Harvard Medical School, Charlestown, Massachusetts 02129
Magicin, a protein that we isolated earlier as an interactor of the neurofibromatosis 2 protein merlin, was independently identified as MED28, a subunit of the mammalian Mediator complex. Mediator complex is an evolutionarily conserved transcriptional cofactor, which plays an essential role in positive and negative gene regulation. Distinct Mediator subunit composition is thought to contribute to gene regulation specificity based on the interaction of specific subunits with subsets of transcription factors. Here we report that down-regulation of Med28 expression in NIH3T3 cells results in a significant induction of several genes associated with smooth muscle cell (SMC) differentiation. Conversely, overexpression of MED28 represses expression of SMC genes, in concordance with our knockdown data. More importantly, multipotent mesenchymal-derived murine precursors can transdifferentiate into SMCs when Med28 is down-regulated. Our data also show that Med28 functions as a negative regulator of SMC differentiation in concert with other Mediator subunits including Med6, Med8, and Med18 within the Mediator head module. Our results provide strong evidence that MED28 may function as a scaffolding protein by maintaining the stability of a submodule within the head module and that components of this submodule act together in a gene regulatory program to suppress SMC differentiation. The results presented here demonstrate for the first time that the mammalian Mediator subunit MED28 functions as a repressor of SMC differentiation, which could have implications for disorders associated with abnormalities in SMC growth and differentiation, including atherosclerosis, asthma, hypertension, and smooth muscle tumors.
Received for publication, August 8, 2007
* This work was supported in part by National Institutes of Health Grant NS24279, and NS45776. Kim Beyer was supported by a research fellowship from the German Research Foundation (DFG, BE 2673/1-1). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains a supplemental figure and a supplemental table.
1 The first two authors contributed equally to this work.
2 To whom correspondence should be addressed: Center for Human Genetic Research, Massachusetts General Hospital, Simches Research Bldg., 185 Cambridge St., Boston, MA 02114. Tel.: 617-724-9733; Fax: 617-726-3655; E-mail: ramesh{at}helix.mgh.harvard.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. Tsutsui, H. Umemura, A. Tanaka, F. Mizuki, Y. Hirose, and Y. Ohkuma
Human mediator kinase subunit CDK11 plays a negative role in viral activator VP16-dependent transcriptional regulation
Genes Cells,
August 1, 2008;
13(8):
817 - 826.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|